These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 23076367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Suppression of LPS-induced epithelial-mesenchymal transition by aqueous extracts of Prunella vulgaris through inhibition of the NF-κB/Snail signaling pathway and regulation of EMT-related protein expression.
    Cho IH, Jang EH, Hong D, Jung B, Park MJ, Kim JH.
    Oncol Rep; 2015 Nov; 34(5):2445-50. PubMed ID: 26324883
    [Abstract] [Full Text] [Related]

  • 4. Shikonin as an inhibitor of the LPS-induced epithelial-to-mesenchymal transition in human breast cancer cells.
    Hong D, Jang SY, Jang EH, Jung B, Cho IH, Park MJ, Jeong SY, Kim JH.
    Int J Mol Med; 2015 Dec; 36(6):1601-6. PubMed ID: 26498588
    [Abstract] [Full Text] [Related]

  • 5. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J, Alvarado-Muñoz JF, Escobar-Arriaga E, Ulloa-Aguirre A, de Jesús Ibarra-Sánchez M.
    BMC Cancer; 2019 Jul 23; 19(1):728. PubMed ID: 31337349
    [Abstract] [Full Text] [Related]

  • 6. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
    Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.
    J Exp Clin Cancer Res; 2013 Sep 05; 32(1):62. PubMed ID: 24011086
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Resveratrol inhibits LPS-induced epithelial-mesenchymal transition in mouse melanoma model.
    Chen MC, Chang WW, Kuan YD, Lin ST, Hsu HC, Lee CH.
    Innate Immun; 2012 Oct 05; 18(5):685-93. PubMed ID: 22344225
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.
    Kim Y, Lee EJ, Jang HK, Kim CH, Kim DG, Han JH, Park SM.
    J Gastroenterol Hepatol; 2016 Jun 05; 31(6):1220-8. PubMed ID: 26574150
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Toll-like receptor 4 shRNA attenuates lipopolysaccharide-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells in rats.
    Tang S, Jiang X, Wu L, Chen S, Chen L, Jiang J, Yan P, Wang F, Tu K, Wang D, Gu J, Zhao L.
    Biomed Pharmacother; 2018 Nov 05; 107():1210-1217. PubMed ID: 30257335
    [Abstract] [Full Text] [Related]

  • 13. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY, Weber CE, Mi Z, Wai PY, Cuevas BD, Kuo PC.
    J Am Coll Surg; 2013 Jul 05; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [Abstract] [Full Text] [Related]

  • 14. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.
    Li X, Kong X, Huo Q, Guo H, Yan S, Yuan C, Moran MS, Shao C, Yang Q.
    Cancer Sci; 2011 Jun 05; 102(6):1151-7. PubMed ID: 21371176
    [Abstract] [Full Text] [Related]

  • 15. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.
    Chen TC, Hsu YL, Tsai YC, Chang YW, Kuo PL, Chen YH.
    J Mol Med (Berl); 2014 Jan 05; 92(1):53-64. PubMed ID: 24005829
    [Abstract] [Full Text] [Related]

  • 16. 2-Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE-2 stem cells via NF-κB/HIF-1 signaling pathway inactivation and EMT reversal.
    Wu SL, Li YJ, Liao K, Shi L, Zhang N, Liu S, Hu YY, Li SL, Wang Y.
    Oncol Rep; 2017 Feb 05; 37(2):793-802. PubMed ID: 28000883
    [Abstract] [Full Text] [Related]

  • 17. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition.
    Li S, Zhang J, Yang H, Wu C, Dang X, Liu Y.
    Sci Rep; 2015 Jul 15; 5():12410. PubMed ID: 26174737
    [Abstract] [Full Text] [Related]

  • 18. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C, Li M, Guo T, Wang S, Huang W, Yang K, Liao Z, Wang J, Zhang F, Wang H.
    Phytomedicine; 2019 May 15; 58():152740. PubMed ID: 31005718
    [Abstract] [Full Text] [Related]

  • 19. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
    Lin ML, Lu YC, Chen HY, Lee CC, Chung JG, Chen SS.
    Mol Carcinog; 2014 May 15; 53(5):360-79. PubMed ID: 23192861
    [Abstract] [Full Text] [Related]

  • 20. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.
    Carcinogenesis; 2013 Apr 15; 34(4):874-84. PubMed ID: 23275155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.